Zsolt Hepp - Global Health Outcomes Strategy and Research, Allergan Inc

基本信息

浏览量：19

职业迁徙

个人简介

暂无内容

研究兴趣

论文共 75 篇作者统计合作学者相似作者

按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选

Patient Preferences for First-Line Treatment of Locally Advanced or Metastatic Urothelial Carcinoma: an Application of Multidimensional Thresholding

Andrea B. Apolo,Christine Michaels-Igbokwe,Nicholas I. Simon,David J. Benjamin,Mallory Farrar,Zsolt Hepp,Lisa Mucha,Sebastian Heidenreich,Katelyn Cutts,Nicolas Krucien, Natasha Ramachandran,John L. Gore

Patient (2024)

引用0浏览0WOS引用

REAL-WORLD ELIGIBILITY AND UTILIZATION OF AVELUMAB MAINTENANCE IN PATIENTS WITH LOCALLY ADVANCED OR METASTATIC UROTHELIAL CARCINOMA

K. Morgans Alicia,P. Sonpavde Guru, Shih Vanessa,Wright Phoebe,Hepp Zsolt, L. Willmon Candice,Chang Nancy, Sesterhenn Steven, Naga Sai Sriteja Boppudi,Powles Thomas

Urologic Oncology Seminars and Original Investigations (2024): S26-S27

引用0浏览0WOS引用

Real-World Treatment Patterns and Clinical Outcomes in Patients with Locally Advanced or Metastatic Urothelial Carcinoma by Eligibility for Maintenance Avelumab

Alicia K. Morgans,Guru P. Sonpavde, Vanessa Shih,Phoebe Wright,Zsolt Hepp, Candice L. Willmon,Nancy N. Chang,Lisa Mucha, Sai Sriteja Boppudi Naga,Thomas Powles

CLINICAL GENITOURINARY CANCERno. 1 (2024)

引用1浏览0引用

Real-world Survival and Economic Burden among Patients with Locally Advanced or Metastatic Urothelial Carcinoma in the United States

Ronald C. Chen,Rupali Fuldeore,Alexandra Greatsinger,Zsolt Hepp,Qing Liu,Phoebe Wright, Bin Xie,Hongbo Yang,Christopher Young,Adina Zhang,Lisa Mucha

Urologic Oncology Seminars and Original Investigations（2024）

引用0浏览0WOS引用

Systematic Literature Review (SLR) and Network Meta-Analysis (NMA) of First-Line Therapies (1L) for Locally Advanced/metastatic Urothelial Carcinoma (La/muc)

Lisa Bloudek,Phoebe Wright,Caroline McKay,Christina Louise Derleth,Jennifer Susan Lill,Enrique Lenero,Zsolt Hepp,Scott David Ramsey,Sean D. Sullivan,Beth Devine

Current Oncologyno. 4 (2023): 3637-3647

引用6浏览0WOS引用

Real-world Treatment Patterns and Clinical Outcomes with First-Line Therapy in Patients with Locally Advanced/metastatic Urothelial Carcinoma by Cisplatin-Eligibility

Alicia K. Morgans,Matthew D. Galsky,Phoebe Wright,Zsolt Hepp,Nancy Chang, Candice L. Willmon,Steve Sesterhenn,Yutong Liu,Guru P. Sonpavde

UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS（2023）

引用8浏览0WOS引用

Benchmarking Maintenance Therapy Survival in First-Line Platinum-Based Chemotherapy–Treated Patients with Advanced Urothelial Carcinoma Using Simulated Disease Modeling

Matthew Galsky,Heidi S. Wirtz,Brian Bloudek,Zsolt Hepp,Mallory Farrar,Jack Timmons,Enrique Lenero,Thomas Powles

CLINICAL EPIDEMIOLOGY（2023）

引用1浏览0WOS引用

CO24 Simulating the Impact of First-Line Treatment Choice on Survival among Patients with Locally Advanced/Metastatic Urothelial Carcinoma Considered Cisplatin Ineligible

M. D. Galsky,G. P. Sonpavde,B. Bloudek, M. Farrar,Z. Hepp, J. Timmons, R. Dillon,T. Powles

Value in Healthno. 6 (2023): S18-S18

引用0浏览0引用

加载更多

作者统计

合作学者

合作机构

D-Core

合作者
学生
导师

暂无相似学者，你可以通过学者研究领域进行搜索筛选

数据免责声明

页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果，我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问，可以通过电子邮件方式联系我们：report@aminer.cn